GEP20094626B - (s,s)-reboxetine for treating peripheral neuropathy - Google Patents

(s,s)-reboxetine for treating peripheral neuropathy

Info

Publication number
GEP20094626B
GEP20094626B GEAP200010659A GEAP2000010659A GEP20094626B GE P20094626 B GEP20094626 B GE P20094626B GE AP200010659 A GEAP200010659 A GE AP200010659A GE AP2000010659 A GEAP2000010659 A GE AP2000010659A GE P20094626 B GEP20094626 B GE P20094626B
Authority
GE
Georgia
Prior art keywords
reboxetine
peripheral neuropathy
treating peripheral
treating
medicament
Prior art date
Application number
GEAP200010659A
Inventor
Erik H F Wong
Duncan P Taylor
Robert Macarthur
Robert Clyde Marshall
Pasquale Cetera
Lars Birgerson
Saeeduddin Ahmed
Original Assignee
Pharmacia And Upjohn Company Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia And Upjohn Company Llc filed Critical Pharmacia And Upjohn Company Llc
Publication of GEP20094626B publication Critical patent/GEP20094626B/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention provides the use of optically pure (S,S)-reboxetine, or a pharmaceutically acceptable salt thereof, said compound being substantially free of (R,R)-reboxetine, in the manufacture of a medicament for the treatment or prevention of peripheral neuropathy.
GEAP200010659A 1999-07-01 2000-06-22 (s,s)-reboxetine for treating peripheral neuropathy GEP20094626B (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US14196899A 1999-07-01 1999-07-01
US14413199A 1999-07-16 1999-07-16
US15825699A 1999-10-06 1999-10-06
US17038199A 1999-12-13 1999-12-13

Publications (1)

Publication Number Publication Date
GEP20094626B true GEP20094626B (en) 2009-03-10

Family

ID=79330746

Family Applications (2)

Application Number Title Priority Date Filing Date
GEAP200010659A GEP20094626B (en) 1999-07-01 2000-06-22 (s,s)-reboxetine for treating peripheral neuropathy
GEAP200010717A GEP20094628B (en) 1999-07-01 2000-06-22 (s,s)-reboxetine for treating fibromyalgia and other somatoform disorders

Family Applications After (1)

Application Number Title Priority Date Filing Date
GEAP200010717A GEP20094628B (en) 1999-07-01 2000-06-22 (s,s)-reboxetine for treating fibromyalgia and other somatoform disorders

Country Status (1)

Country Link
GE (2) GEP20094626B (en)

Also Published As

Publication number Publication date
GEP20094628B (en) 2009-03-10

Similar Documents

Publication Publication Date Title
AP1782A (en) Use of compounds ?-D or ?-L nucleoside for treating hepatitis C virus.
AU7031500A (en) Therapeutic quinazoline compounds
AU2002236765A1 (en) Pharmaceutical combination for the treatment of cancer containing a 4-quinazolineamine and another anti-neoplastic agent
EP2087892A3 (en) (S,S) reboxetine for treating age associated learning and mental disorders
WO2003009838A1 (en) Use of stilbene compounds in preparing medicaments for treating or preventing diabetes and diseases associated with retrovirus
NZ334124A (en) Use of the chelating agent clioquinol, with vitamin B12 for the manufacture of a pharmaceutical composition for the treatment of alzheimer's disease
AU2001276689A1 (en) Novel remedies for cancer
MY119375A (en) Treatment of tinnitus using neuroprotective agents
CZ225995A3 (en) The use of riluzol for preparing medicament intended for treating neuronal degeneration caused by aids
HK1025036A1 (en) Novel cryptophycin derivatives as anti-neoplastic agents
WO2000051582A3 (en) Methods for treating apnea and apnea disorders using optically pure r(+)ondansetron
IL143985A0 (en) New use of melagatran
GB9907571D0 (en) Compounds
AU3919001A (en) Use of 2-methyl-thiazolidin-2,4-dicarboxylic acid (2-mtdc) and/or physiologically compatible salts for treating and/or preventing cancers
EP0869786A4 (en) Pharmaceutical compounds
NZ515685A (en) Use of riluzole for the treatment of multiple sclerosis
GEP20094626B (en) (s,s)-reboxetine for treating peripheral neuropathy
EP1632234A3 (en) (S,S)-reboxetine for treating chronic fatigue syndrome
AU1230800A (en) Controlled delivery of antidepressants
GB0129962D0 (en) Method of treatment
MY132436A (en) Use of allylamine derivatives such as terbinafine, in the manufacture of a medicament for the treatment of helicobacter pylori infection of associated diseases
MX9604692A (en) Quinoxaline derivatives for treating tinnitus.
HK1050480A1 (en) Use of 2-amino-3,4-dihydro-quinazolines for producing a medicament for treating or preventing diseases caused by ischaemic conditions.
AU5434899A (en) Cancer treatment
PL367628A1 (en) Use of an alkanoyl l-carnitine for the preparation of a medication to treat anhedonia